Nicholas Investment Partners, LP Iovance Biotherapeutics, Inc. Transaction History

Nicholas Investment Partners, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$28.67 - $52.59 $14.6 Million - $26.7 Million	-507,651 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$28.04 - $50.26 $23,469 - $42,067	837 Added 0.17%	507,651 $23.6 Million
Q3 2020 Nov 13, 2020	BUY	$27.75 - $36.3 $11.7 Million - $15.3 Million	422,298 Added 499.67%	506,814 $16.7 Million
Q2 2020 Aug 12, 2020	SELL	$27.21 - $41.0 $2.65 Million - $4 Million	-97,473 Reduced 53.56%	84,516 $2.32 Million
Q1 2020 May 13, 2020	BUY	$19.54 - $38.85 $828,710 - $1.65 Million	42,411 Added 30.39%	181,989 $5.45 Million
Q4 2019 Feb 13, 2020	BUY	$17.95 - $29.41 $2.51 Million - $4.1 Million	139,578 New	139,578 $3.86 Million

319

243M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $923M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.